Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829191 · ClinicalTrials.gov registry record · NA
Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)
A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 1
- Study location
NCT01829191: Completed NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
NCT01829191 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 174 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01829191, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to investigate whether novel soft contact lens optical designs can slow myopia progression
Primary Outcome
Cycloplegic spherical equivalent auto refraction of the subject's right eye was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measures, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values in spherical refraction indicate progression in Myopia.
Conditions Studied
Interventions
- DEVICE Soft Contact Test Lens A
- DEVICE Soft Contact Test Lens C
Study Locations (1)
Massachusetts
- - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2008-04-01 |
| Est. Completion | 2010-05-01 |
| Phase | NA |
What the finished NCT01829191 record still lists
NCT01829191 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Soft Contact Test Lens A is the first listed.
NCT01829191 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01829191 about?
NCT01829191 is a clinical study titled "Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)". This study is to investigate whether novel soft contact lens optical designs can slow myopia progression
What is the current status of trial NCT01829191?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2008-04-01. Estimated completion is 2010-05-01.
What conditions does trial NCT01829191 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01829191?
The interventions under investigation include: Soft Contact Test Lens A (DEVICE), Soft Contact Test Lens C (DEVICE).
Who is sponsoring clinical trial NCT01829191?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01829191 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01829191's enrollment target sits among peer trials
174 27th of 90 higher than 64 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- NCT04729114 · 174 participants · Phase 1
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- NCT04884035 · 174 participants · Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- NCT05075980 · 174 participants · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI